Man Group
APEN

Man Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Man Group’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– – – 554
2022
Q2 		– Sell
-24,164
Closed -$146K – 2496
2022
Q1 		$146K Buy
+24,164
New +$147K ﹤0.01% 2009

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Man Group's APEN Position: Q1 2023 in Review

Man Group held its Apollo Endosurgery, Inc. (APEN) position steady in Q1 2023 at 0 shares worth $9.92M. The position accounts for 0.04% of the portfolio, ranked #554.

Man Group first reported a position in APEN in Q1 2022 and has held it in 1 quarter since. The position peaked at $146K in Q1 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Man Group held 0 shares of Apollo Endosurgery, Inc. worth $9.92M as of Q1 2023.
  • Man Group left its Apollo Endosurgery, Inc. share count unchanged in Q1 2023.
  • Apollo Endosurgery, Inc. made up 0.04% of Man Group's portfolio in Q1 2023, its #554 holding.
  • Man Group first reported a position in Apollo Endosurgery, Inc. in Q1 2022 and has held it in 1 quarter since.
  • Man Group's Apollo Endosurgery, Inc. position peaked at $146K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.